Zoetis, formerly Pfizer Animal Health, announces the return of the
Cattle Call grant program and is accepting research proposals for
improving cattle reproduction or developing models for managing cattle
pain.
The Cattle Call supports the development of new products and services
that improve the health and productivity of beef and dairy cattle. In
2013, Zoetis will fund one or more researchers with a grant of up to
$150,000, with minimum funding of $25,000.
“The inaugural Cattle Call grant program in 2012 successfully brought
forth many new ideas and technologies that are helping to address
important needs in the veterinary and cattle industries,” says Michelle
Haven, PhD, senior vice president, corporate development, alliances and
solutions, Zoetis. “We are very excited about the research we helped
fund for improving productivity and immune function in cattle, and we
look forward to building on our partnerships to expand research into
reproduction and pain management in 2013.”
Innovations in research would not be possible without partnerships with
industry experts, Dr. Haven says.
“At Zoetis, we’re dedicated to research collaborations that benefit all
livestock,” she says. “The 2013 Cattle Call program will bring together
research perspectives from across the cattle industry to advance our
mission to continuously improve the health and care of animals worldwide
and to advance veterinary science and education.”
For more information about the 2013 Cattle Call program or to obtain an
application, contact cattlecall@zoetis.com.
The application deadline is April 30, 2013. All applicants must be in
good standing in their professional organizations (e.g., American
Association of Bovine Practitioners, American Dairy Science Association,
etc.). Research must be conducted in the United States. Candidates will
be notified of the research committee’s decision by May 31, 2013.
About Zoetis
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on a 60-year
history as the animal health business of Pfizer, Zoetis discovers,
develops, manufactures and markets veterinary vaccines and medicines,
with a focus on both farm and companion animals. The company generated
annual revenue of $4.2 billion in fiscal 2011. Zoetis has more than
9,500 employees and a local presence in approximately 70 countries,
including 29 manufacturing facilities in 11 countries. Its products
serve veterinarians, livestock producers and people who raise and care
for farm and companion animals in 120 countries.
Wendy Elliot
Zoetis
646-894-0684
wendy.e.elliot@zoetis.com
or
Lindsey Langemeier
Bader Rutter
402-434-5308
llangemeier@bader-rutter.com